Generic placeholder image

Current Hypertension Reviews

Editor-in-Chief

ISSN (Print): 1573-4021
ISSN (Online): 1875-6506

General Research Article

Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Arterial Hypertension in Current Medical Practice in Algeria

Author(s): Naima Hammoudi-Bendib, Leila Manamani, Souhila Ouabdesselam, Dalila S. Ouamer, Sofiane Ghemri, Laurene Courouve, Amine Cherif, Lamine Mahi* and Salim Benkhedda

Volume 17 , Issue 1 , 2021

Published on: 24 March, 2020

Page: [75 - 82] Pages: 8

DOI: 10.2174/1573402116666200324144223

open access plus

Abstract

Objective: There are limited data on the management of hypertension (HT) in Algeria. The aim of this study was to assess, in current medical practice, the use and benefits of ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of HT.

Methods: A prospective, observational, multicenter study was performed in 2017. Patients aged ≥ 18 years with suspected or treated HT were included. A 24-hour ABPM was performed at baseline in all patients. Therapeutic decision was taken by the physician according to ABPM results and patients were then followed up to 6 weeks.

Results: The analysis included 1027 patients (mean age, 51.0 years; women, 61.6%) with treated HT (37.3%) or suspected HT (62.7%). Major cardiovascular risk factors were diabetes (15.7%) and lipid disorders (7.2%). ABPM was pathological in 55.1% of patients on antihypertensive treatment and in 60.8% of patients with suspected HT. A therapeutic adjustment or a treatment switch was performed after pathological ABPM in 37.4% of patients already on antihypertensive treatment and an antihypertensive therapy was initiated in 54.9% of patients with initially suspected HT.

Conclusion: This study is the first evaluation of the usefulness of ABPM for the management of HT in Algeria. Our results emphasize that ABPM is a highly valuable method for avoiding the whitecoat effect and for detecting patients who are insufficiently treated with antihypertensive drugs.

Keywords: Arterial hypertension, ambulatory blood pressure monitoring, office blood pressure, antihypertensive treatment, white coat effect, antihypertensive drugs.

Graphical Abstract
[1]
Benkhedda B, Chibane A, Temmar M, et al. Prévalence de l’HTA en Algérie: Enquête nationale SAHA Abstract XIV; Conférence européenne d’hypertension Paris Juin 2004.
[2]
MSPRH – Direction de la Prévention. Mesure des facteurs de risque des maladies non transmissibles dans deux wilayas pilotes en Algérie (Approche STEPwise de l’OMS) Rapport final – Algérie 2005.
[3]
Institut National de Santé Publique. Enquête nationale de santé: Transition épidémiologique et système de santé. Projet TAHINA 2007.
[4]
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159-219.
[http://dx.doi.org/10.1093/eurheartj/eht151] [PMID: 23771844]
[5]
Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2224-60.
[http://dx.doi.org/10.1016/S0140-6736(12)61766-8] [PMID: 23245609]
[6]
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-13.
[http://dx.doi.org/10.1016/S0140-6736(02)11911-8] [PMID: 12493255]
[7]
Williams B, Mancia G, Spiering W, et al. List of authors/Task Force members. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2018; 36(12): 2284-309.
[http://dx.doi.org/10.1097/HJH.0000000000001961] [PMID: 30379783]
[8]
Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49(1): 69-75.
[http://dx.doi.org/10.1161/01.HYP.0000252676.46043.18] [PMID: 17159087]
[9]
Tocci G, Rosei EA, Ambrosioni E, et al. Blood pressure control in Italy: Analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012; 30(6): 1065-74.
[http://dx.doi.org/10.1097/HJH.0b013e3283535993] [PMID: 22573073]
[10]
Girerd X, Hanon O, Pannier B, Vaïsse B, Mourad JJ. Trends in the use of antihypertensive drugs in France from 2002 to 2012: FLAHS surveys. Ann Cardiol Angeiol (Paris) 2013; 62(3): 210-4.
[http://dx.doi.org/10.1016/j.ancard.2013.04.011] [PMID: 23759733]
[11]
Nibouche D. Prevalence of blood pressure target achievement in Algerian hypertensives: The PACT trial. XIXes Journées Européennes de de la Société Française de Cardiologie 2009; 14-7.
[12]
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311(5): 507-20.
[http://dx.doi.org/10.1001/jama.2013.284427] [PMID: 24352797]
[13]
Haute Autorité de Santé. Société Française d’Hypertension Artérielle 2016. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2016-10/fiche_memo_hta__mel.pdf
[14]
Verdecchia P, Angeli F, Gattobigio R. Clinical usefulness of ambulatory blood pressure monitoring. J Am Soc Nephrol 2004; 15(Suppl. 1): S30-3.
[http://dx.doi.org/10.1097/01.ASN.0000093241.62751.95] [PMID: 14684668]
[15]
Parati G, Stergiou G, O’Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32(7): 1359-66.
[http://dx.doi.org/10.1097/HJH.0000000000000221] [PMID: 24886823]
[16]
Gunawan F, Ng HY, Gilfillan C, Anpalahan M. ambulatory blood pressure monitoring in type 2 diabetes mellitus: A cross-sectional study. Curr Hypertens Rev 2019; 15(2): 135-43.
[http://dx.doi.org/10.2174/1573402114666180607090205] [PMID: 29875006]
[17]
Harianto H, Valente M, Hoetomo S, Anpalahan M. The clinical utility of ambulatory blood pressure monitoring (ABPM): A review. Curr Hypertens Rev 2014; 10(4): 189-204.
[http://dx.doi.org/10.2174/157340211004150319121321] [PMID: 25801624]
[18]
Kario K. Perfect 24-hr Blood pressure control: Up-to-date 2020. Curr Hypertens Rev 2020; 16(1): 2-10.
[http://dx.doi.org/10.2174/157340211601191226162545] [PMID: 32065084]
[19]
Kario K. Differential approaches are much needed for “Real World” management of hypertension in the era of “Hypertension Paradox”. Curr Hypertens Rev 2018; 14(1): 2-5.
[http://dx.doi.org/10.2174/157340211401180611103932] [PMID: 29943699]
[20]
Kario K, Shimbo D, Tomitani N, Kanegae H, Schwartz JE, Williams B. The first study comparing a wearable watch-type blood pressure monitor with a conventional ambulatory blood pressure monitor on in-office and out-of-office settings. J Clin Hypertens (Greenwich) 2020; 22(2): 135-41.
[http://dx.doi.org/10.1111/jch.13799] [PMID: 31955505]
[21]
Kario K, Shin J, Chen CH, et al. Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network. J Clin Hypertens (Greenwich) 2019; 21(9): 1250-83.
[http://dx.doi.org/10.1111/jch.13652] [PMID: 31532913]
[22]
Girerd X, Radauceanu A, Achard JM, et al. Evaluation of patient compliance among hypertensive patients treated by specialists. Arch Mal Coeur Vaiss 2001; 94(8): 839-42.
[PMID: 11575214]
[23]
Cherif AB, Bouamra A, Taleb A, et al. Differences in prevalence, treatment and control rates of hypertension between male and female in the area of Blida (Algeria). Ann Cardiol Angeiol (Paris) 2017; 66(3): 123-9.
[http://dx.doi.org/10.1016/j.ancard.2017.04.009] [PMID: 28554703]
[24]
National Institute for Health and Care Excellence (NICE). Hypertension in adults Available from: https://www.nice.org.uk/guidance/qs28/resources/hypertension-in-adults-pdf-2098552495813
[25]
Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006; 12(3): 239-45.
[http://dx.doi.org/10.18553/jmcp.2006.12.3.239] [PMID: 16623608]
[26]
Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens Suppl 1991; 9(8): S42-4.
[PMID: 1839037]
[27]
Omboni S, Parati G, Palatini P, et al. Study on ambulatory monitoring of pressure and lisinopril evaluation. Reproducibility and clinical value of nocturnal hypotension: Prospective evidence from the SAMPLE study. J Hypertens 1998; 16(6): 733-8.
[http://dx.doi.org/10.1097/00004872-199816060-00003] [PMID: 9663912]
[28]
Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: Systematic review and meta-analysis of prospective studies. J Hypertens 2012; 30(3): 449-56.
[http://dx.doi.org/10.1097/HJH.0b013e32834e4aed] [PMID: 22241136]
[29]
McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): A randomised controlled trial. Lancet 2010; 376(9736): 163-72.
[http://dx.doi.org/10.1016/S0140-6736(10)60964-6] [PMID: 20619448]
[30]
McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA 2014; 312(8): 799-808.
[http://dx.doi.org/10.1001/jama.2014.10057] [PMID: 25157723]

© 2022 Bentham Science Publishers | Privacy Policy